See how top analysts and institutions rate STX — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| BofA Securities | Reiterated | Buy | $215 → $255 | 2025-09-24 |
| Bernstein | Initiated | Outperform | $250 | 2025-09-16 |
| Cantor Fitzgerald | Upgrade | Neutral → Overweight | $175 | 2025-07-30 |
| TD Cowen | Reiterated | Buy | $135 → $175 | 2025-07-30 |
| Goldman | Initiated | Buy | $170 | 2025-07-10 |
| BofA Securities | Reiterated | Buy | $125 → $135 | 2025-05-28 |
| BNP Paribas Exane | Upgrade | Underperform → Neutral | $100 | 2025-05-16 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 1 | 15 | 6 | 1 | 0 |
| October 2025 | 1 | 15 | 6 | 2 | 0 |
| September 2025 | 1 | 14 | 7 | 1 | 0 |
| July 2025 | 1 | 14 | 7 | 1 | 0 |
The majority of institutional investors have issued a "Buy" rating for STX, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
